Skip to content

A prospective randomised controlled study to evaluate ankle dorsiflexion after cast immobiliation and percutaneous gastrocnemius lengthening, for neurologic healthy children (6-18) with an symptomatic equinus contracture.

A prospective randomised controlled study to evaluate ankle dorsiflexion after cast immobiliation and percutaneous gastrocnemius lengthening, for neurologic healthy children (6-18) with an symptomatic equinus contracture. - equinus contracture: cast vs percutaneous gastrocnemius lengthening.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38124
Enrollment
80
Registered
2012-04-16
Start date
2012-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

equinus contracture short achilles tendon

Interventions

percutaneous gastrocnemius lengthening

Sponsors

Spaarne Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Patients (boys and girls) between 6-18 years independent walking achieved symptomatic limited ankle dorsi flexion between -10 and 3 degrees (with knee in extension and ankle in neutral position) patient has been treated non-surgically for at least 6 month (NSAIDs, stretching, orthoses and physical therapy) Written informed consent both parents/ guardian (children 6-12 years) written informed consent both parents/ guardian and child (children 12-18 years)

Exclusion criteria

Exclusion criteria: Patients with signs of neurological, orthopaedic or psychiatric disease. Patients with mental retardation Patients with previous surgery on the ankle Patients who were already treated with castimmobilisation because of equinus contracture Patients (12 years or older) whose parents are unable to understand informed consent Patients (12 years or older) or parents who are unable to fill out questionnaires Patients (12 years or older) or parents who are unable to understand treatment

Design outcomes

Primary

MeasureTime frame
Primary end-point will be ankle dorsiflexion.

Secondary

MeasureTime frame
Secondary end-point will be satisfaction, walking pattern, pain, complications, activity level and foot pressure. Functional outcome will be measured by: AOFAS-score and functional mobility scale (FMS).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)